1don MSN
Doctors discover a new dementia that often gets misdiagnosed and 6.5 million people are at risk
Doctors are increasingly alarmed that a type of dementia which closely resembles Alzheimer's may have resulted in the ...
First Patient Expected to be Dosed Next Week with Intranasal Foralumab PET Scan Shows Presence of Untreated Neuroinflammation ...
In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These monoclonal anti-Aβs are proteins made ...
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
OK Magazine on MSN
Donald Trump's health fuels conspiracy theories as congresswoman claims he's taking Alzheimer's drug
Donald Trump’s health is fueling conspiracy theories. South Los Angeles Congresswoman Sydney Kamlager-Dove claimed that Trump ...
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
A Democratic lawmaker's "curious" theory about President Donald Trump's health forced an official White House denial.Rep.
Experts at a roundtable in Boston, Massachusetts, on November 3, 2025, discussed improving early Alzheimer disease diagnosis, addressing workforce and equity gaps, and expanding access to new ...
For the millions of Americans touched by Alzheimer’s disease, 2025 brought major advances in understanding of brain health ...
In August 2024, LEQEMBI was approved for the treatment of mild cognitive impairment (MCI) and mild dementia due to Alzheimer's disease (AD) in adult patients that are apolipoprotein E e4 (ApoE e4)* ...
STOCKHOLM, Nov. 13, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi (lecanemab) has been approved for once every four weeks intravenous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback